…a comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder.
…a mentoring program to provide guidance, direction and advice to help prescribers and key health professionals who are new to the field of Medication Assisted Treatment.
…to offer waiver training for physicians interested in providing buprenorphine treatment under the DATA 2000.
The content of educational resources is overseen by a panel of experienced clinicians, researchers, and educators forming a Clinical Expert Panel.
The program selects and trains mentors, subsequently mentors are matched with mentees and are monitored and supported by the Mentoring Panel. Communications between individual mentors and mentees is primarily via phone and Internet (email, video). A listserv allows mentees and mentors to post questions and to encourage communication among a wide range of providers.
A “Mentor-on-Call” is available, on a rotating basis, to answer questions and to review and respond to postings on the listserv.
The web-based training includes eight hours of modules focused on buprenorphine that, once completed, qualify for the waiver to prescribe. Training continues using the Half-and-Half format (3.75 hours of on-your-own training and 4.25 hours of face-to-face training with an instructor). AAAP focuses on training resident physicians with an emphasis on primary care and psychiatry, AOAAM will emphasize training of rural practicing physicians and ASAM will train primary care and OB-GYN residents. The course content used in existing Physicians’ Clinical Support System for Buprenorphine (PCSS-B) trainings have been revised to include information about other pharmacological strategies (naltrexone and methadone), including matching patients to treatment, as well as recommendations for practice informed by recent research and clinical experience.